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LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCs) like IUDs, implants, and vaginal rings provide long-lasting 
protection, yet these highly effective methods are often out of reach for women in developing countries. Because not 
all health care providers are trained to provide LARCs—and not all family planning programs supply them—women 
often lack access to methods that can be the most effective and appropriate when they want to postpone their first 
pregnancy, delay their next pregnancy, or limit future pregnancies.
The Population Council is working to expand contraceptive options worldwide, with a focus on LARCs. We conduct 
groundbreaking biomedical research, develop new contraceptive options, and shape policies and programs to expand 
access to LARCs.
EXPANDING ACCESS TO LONG-ACTING 
REVERSIBLE CONTRACEPTIVES 
For more information about the Population Council’s work on  
LARCs, visit www.popcouncil.org
The Population Council conducts biomedical, social science, and public health research to deliver solutions
that lead to more effective policies, programs, and technologies that improve lives around the world.
© 2015 The Population Council, Inc.     
CONTRACEPTIVES DEVELOPED BY
THE POPULATION COUNCIL 
COPPER T 380-A/PARAGARD: A non-hormonal IUD  
offering the contraceptive properties of copper to  
prevent pregnancy. Approved in the U.S. for up to 10 
years of use. The most widely used contraceptive  
product in the world.
MIRENA: A hormonal intrauterine system containing  
the progestin levonorgestrel. Approved in the U.S. for  
up to 5 years of use.
JADELLE: A two-rod levonorgestrel implant system inserted 
in the skin of a woman’s upper arm to prevent pregnancy 
for 5 years. Offers the same level of protection as  
Norplant, an earlier six-rod implant that was also developed, 
tested, and brought to market by the Population Council.
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Currently, 170 million women worldwide are using a highly effective contraceptive developed 
by the Council or based on our technology.
SHAPING POLICIES THAT EXPAND
ACCESS TO LARCs 
Annually, the Population Council, the Reproductive Health Sup-
plies Coalition, and the International Federation of Gynecology 
and Obstetrics convene leading experts to map and measure 
an action plan for increasing access to LARCs and advancing 
the goal of universal access to reproductive health services.
COMING SOON: ONE-YEAR
CONTRACEPTIVE VAGINAL RING
Today, Council scientists have developed an 
investigational one-year contraceptive vaginal 
ring that will provide protection for 13 menstrual 
cycles. The ring does not require refrigeration. 
Because it is effective for one year, it will help 
women in developing countries overcome the potential barrier 
of monthly access to a fully stocked pharmacy.
